0.3654
Cosmos Health Inc stock is traded at $0.3654, with a volume of 487.19K.
It is down -5.48% in the last 24 hours and down -16.90% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.3866
Open:
$0.3811
24h Volume:
487.19K
Relative Volume:
0.57
Market Cap:
$13.65M
Revenue:
$59.79M
Net Income/Loss:
$-18.54M
P/E Ratio:
-0.5154
EPS:
-0.7089
Net Cash Flow:
$-10.45M
1W Performance:
-6.28%
1M Performance:
-16.90%
6M Performance:
-43.70%
1Y Performance:
-28.07%
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health Inc
|
0.3654 | 14.44M | 59.79M | -18.54M | -10.45M | -0.7089 |
|
MCK
Mckesson Corporation
|
931.35 | 119.88B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
359.28 | 71.62B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
216.02 | 52.52B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
80.17 | 9.24B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
1.35 | 1.16B | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc Stock (COSM) Latest News
COSM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
COSM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cosmos Health Inc.: Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value - FinanzNachrichten.de
COSM Should I Buy - Intellectia AI
Cosmos Health appoints AI drug discovery expert to advisory board By Investing.com - Investing.com Canada
Cosmos Health appoints AI drug discovery expert to advisory board - Investing.com
Cosmos Health Inc. Appoints Dr. Dimitrios Iliopoulos to Advisory Board to Advance AI-Driven Drug Discovery Initiatives - Quiver Quantitative
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board - Bitget
AI scientist behind ulcerative colitis trial joins Cosmos Health - Stock Titan
Ideas Watch: Is Cosmos Health Inc in a consolidation phase2025 Major Catalysts & Accurate Trade Setup Notifications - baoquankhu1.vn
Cosmos Health’s antimicrobial skin cleanser now available at Superdrug By Investing.com - Investing.com Australia
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value - Finviz
Cosmos Health Continues UK Retail Expansion for C-Scrub; - GlobeNewswire
User - The Chronicle-Journal
Cosmos Health’s antimicrobial cleanser now available at Tesco By Investing.com - Investing.com Canada
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer - Finviz
Cosmos Health’s antimicrobial skin cleanser now available at Superdrug - Investing.com South Africa
Cosmos Health Expands Retail Footprint in the UK - Intellectia AI
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer - The Manila Times
Cosmos Health Inc. Expands UK Presence with C-Scrub Wash Launch at Superdrug - Quiver Quantitative
Cosmos Health’s antimicrobial cleanser now available at Tesco - Investing.com
Cosmos Health (COSM) Expands UK Reach with New Product in Tesco - GuruFocus
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK’s Largest Retailer - markets.businessinsider.com
Cosmos Health Inc. - Via Ritzau
Cosmos Health Showcases at World Health Expo Dubai 2026 - Intellectia AI
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026 - The National Law Review
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer - Bitget
Cosmos Health Showcases Expanding Brand Portfolio at World Healt - GuruFocus
Cosmos Health Inc. Showcases Innovative Nutraceuticals at World Health Expo Dubai 2026 - Quiver Quantitative
Insiders Who Purchased US$2.38m Of Cosmos Health Stock May Not Have Expected 15% Tumble - Yahoo Finance
Insiders' US$2.38m Investments In Red Following Cosmos Health's US$2.3m Dip In Market Value - simplywall.st
Investors Give Cosmos Health Inc. (NASDAQ:COSM) Shares A 27% Hiding - simplywall.st
Will Cosmos Health Inc. benefit from sector rotationJuly 2025 Rallies & Weekly Market Pulse Alerts - mfd.ru
COSM PE Ratio & Valuation, Is COSM Overvalued - Intellectia AI
Cosmos Health CEO Siokas acquires $145,000 in shares By Investing.com - Investing.com Australia
Cosmos Health CEO Siokas acquires $145,000 in shares - Investing.com Nigeria
Is Cosmos Health Inc. part of any major indexJuly 2025 Institutional & High Accuracy Trade Signal Alerts - mfd.ru
Portfolio Update: Is Cosmos Health Inc in a consolidation phaseJuly 2025 EndofMonth & Momentum Based Trading Ideas - baoquankhu1.vn
Cosmos Health (COSM) CEO swaps $145K company debt for shares - Stock Titan
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):